Ifinatamab deruxtecan trials for Lung cancer

All Ifinatamab deruxtecan trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Ifinatamab deruxtecan for Lung cancer

• A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)
  NCT06362252 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 58 locations
• A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
  NCT06203210 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 229 locations
• A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
  NCT06780085 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 34 locations

Common questions

How many trials study Ifinatamab deruxtecan for Lung cancer?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.